南微医学

688029.SH

Wind Industry: 医疗保健 > 医疗设备与服务 > 医疗保健设备与用品 > 医疗保健设备

公司成立于2000年，主要从事微创医疗器械的研发、制造和销售。秉持着“以科技和创新服务临床”的宗旨以及“守正创新、匠心致远”的发展理念，公司致力于帮助全球医疗机构提高医疗水平，减少病人痛苦，降低医疗支出。公司先后在美国、德国、荷兰、英国、法国、日本、葡萄牙和瑞士等地设立全资子公司并在国内建有18个营销分中心，正在形成覆盖全球主要市场的营销网络，产品及服务可及90多个国家和地区。经过20余年的创新发展，公司逐步形成了内镜诊疗、肿瘤介入、微创神经外科三大产品系列，成为微创诊疗领域具有较高科研创新实力和市场竞争优势、业绩高速增长的细分行业领先企业。公司主要产品包括配合内镜使用的内镜诊疗器械、微波/射频消融设备及耗材、一次性内镜等三大系列。内镜诊疗器械主要包括活检类、止血和闭合类、EMR/ESD类、扩张类、ERCP类、EUS/EBUS类等六大类60多种上百个规格系列的产品；微波/射频消融主要包括消融仪和消融针系列产品；一次性内镜主要包括一次性胆胰成像系统(胆道镜)、一次性支气管镜及相关耗材等产品。

ESG Score Industry Ranking:
5 / 151 (医疗保健设备与用品)

ESG Rating Distribution(医疗保健设备与用品)

0.66%

AAA

3.31%

15.23%

21.19%

BBB

49.67%

7.95%

CCC

Trend of Rating

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：8.09Updated on 2026-10-29

08.0910

Management & Practices Score：5.10Updated on 2026-10-11

05.107

Controversies Score：2.99Updated on 2026-10-29

02.993

ESG Score Comparison

Indicator	Company Score	Industry Average	Weight
Environmental	6.96	2.78	5.84%
Social	7.48	3.82	65.37%
Governance	6.88	5.86	28.77%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB

More Details

Peer Comparison(151 companies in the industry) ?

Ranking	Code	Security Name	ESG Rating	ESG Score	Controversies Score	Management & Practices Score	Environmental	Social	Governance
1	688139.SH	海尔生物	AAA	8.91	2.98	5.93	8.20	8.84	7.69
2	002223.SZ	鱼跃医疗	AA	8.44	2.97	5.47	7.99	7.85	7.72
3	300760.SZ	迈瑞医疗	AA	8.41	2.99	5.42	6.67	7.34	8.87
4	300888.SZ	稳健医疗	AA	8.37	3.00	5.38	7.76	7.52	8.03
5	688029.SH	南微医学	AA	8.09	2.99	5.10	6.96	7.48	6.88
6	300298.SZ	三诺生物	AA	7.90	2.98	4.93	5.48	6.97	7.51
7	605369.SH	拱东医疗	A	7.85	2.97	4.88	4.37	7.00	7.42
8	300981.SZ	中红医疗	A	7.77	2.97	4.80	2.82	6.96	7.44
9	300832.SZ	新产业	A	7.75	2.88	4.87	4.67	6.99	7.35
10	0853.HK	微创医疗	A	7.72	2.90	4.82	6.88	7.64	5.17